ABOUT PROLOR

New research has found that a particular type of protein found in the blood can help reduce the risk of developing type 2 diabetes for ten years or more.

A new study from Cold Spring Harbor Laboratory (CSHL) reports surprising results that suggest that the devastating neuromuscular disease, spinal muscular atrophy (SMA), might not exclusively affect the motor neurons in the spinal cord as has long been thought.

NES-ZIONA, Israel, Aug. 4, 2011 /PRNewswire/ -- PROLOR Biotech, Inc. (NYSE Amex: PBTH) today reported positive results from a Phase II clinical trial of its long-acting CTP-modified version of human growth hormone (hGH-CTP) in growth hormone deficient adults.

Blocking a growth factor receptor cripples cancer growth in a form of T cell leukemia.